Exchange: NASDAQ·Updated 12:49 PM EDT
IRD logo

IRD Opus Genetics Inc.

$3.56
$0.13
(3.52%)
Today
Reported EarningsAug 6
Mkt Cap$306.99M
Vol287,213.00

About IRD

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
76

Extremely Bullish Sentiment

How do you feel about IRD?

Advertisement|Remove ads.